During the past decade, VA Central California Health Care System, Fresno conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VA Central California Health Care System, Fresno" #1 sponsor was "US Department of Veterans Affairs" with 5 trials, followed by "VA Office of Research and Development" with 3 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Forest Laboratories" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VA Central California Health Care System, Fresno" #1 collaborator was "American Diabetes Association" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "Sanofi-Synthelabo" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "VA Central California Health Care System, Fresno" are "Atrial Fibrillation" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "Cerebrovascular Accident" (1 trials), "Colorectal Cancer" (1 trials) and "Death, Sudden" (1 trials). Many other conditions were trialed in "VA Central California Health Care System, Fresno" in a lesser frequency.

Most popular intervention types in "VA Central California Health Care System, Fresno" are "Drug" (7 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rosiglitazone" (2 trials), "Abiraterone Acetate" (1 trials), "Amiodarone" (1 trials), "Apalutamide" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "VA Central California Health Care System, Fresno" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "VA Central California Health Care System, Fresno". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in VA Central California Health Care System, Fresno, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VA Central California Health Care System, Fresno, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".